Literature DB >> 8890726

Episodic secretion of activin A in pregnant women.

A Gallinelli1, R Gallo, A D Genazzani, M L Matteo, A Caruso, T K Woodruff, F Petraglia.   

Abstract

The aim of the present study was to determine the characteristics of activin A secretion in women with normal and abnormal pregnancy. With this purpose, a prospective study was done to evaluate the putative pulsatile pattern of serum activin A in serial specimens of blood collected during a certain amount of time (every 15 min for 3 h). A group of pregnant women (N = 24) participated in a cross-sectional study. They were subdivided into three groups: healthy pregnant women (N = 8), patients with preterm labor (N = 8) and patients with gestational diabetes (N = 8) before and after insulin therapy. Secretory pulses of serum activin A were determined in all patients with a specific frequency and amplitude by using two different computerized analyses, i.e. DETECT and CLUSTER. Mean +/- SEM values of serum activin A were significantly higher in patients with preterm labor and gestational diabetes than in controls (p < 0.01), showing a significant decrease following insulin therapy in diabetic patients (p < 0.01). Specific pulses of serum activin A levels were observed in all women. The mean pulse frequency did not change significantly between healthy controls and the different pathological groups. Patients with gestational diabetes after insulin therapy showed a pulse frequency that was significantly higher than in controls (p < 0.05). When the mean peak amplitude of activin A pulses was evaluated, patients with preterm labor or gestational diabetes showed values that were significantly higher than in healthy pregnant women (p < 0.01) A significant, inverse correlation between pulse frequency and amplitude was found both in healthy pregnant women (p < 0.05) and in patients with gestational diabetes (p < 0.001). The present study showed that circulating activin A levels in pregnant women change in a pulsatile pattern whose pulse amplitude is modified in the presence of gestational diseases, such as preterm labor or gestational diabetes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890726     DOI: 10.1530/eje.0.1350340

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

Review 1.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

Review 2.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 3.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

4.  Short-term energy deprivation alters activin a and follistatin but not inhibin B levels of lean healthy women in a leptin-independent manner.

Authors:  Vasiliki A Moragianni; Konstantinos N Aronis; John P Chamberland; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

5.  Activin A stimulates insulin secretion in cultured human pancreatic islets.

Authors:  P Florio; S Luisi; P Marchetti; R Lupi; L Cobellis; C Falaschi; H Sugino; R Navalesi; A R Genazzani; F Petraglia
Journal:  J Endocrinol Invest       Date:  2000-04       Impact factor: 4.256

6.  Activin-A in myometrium: characterization of the actions on myometrial cells.

Authors:  Pasquapina Ciarmela; Ezra Wiater; Wylie Vale
Journal:  Endocrinology       Date:  2008-01-31       Impact factor: 4.736

7.  Serum activin A and follistatin levels in gestational diabetes and the association of the Activin A-Follistatin system with anthropometric parameters in offspring.

Authors:  Silvia Näf; Xavier Escote; Mónica Ballesteros; Rosa Elena Yañez; Inmaculada Simón-Muela; Pilar Gil; Gerard Albaiges; Joan Vendrell; Ana Megia
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

8.  First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus.

Authors:  Ravi Thadhani; Camille E Powe; May Lee Tjoa; Eliyahu Khankin; Jun Ye; Jeffrey Ecker; Alan Schneyer; S Ananth Karumanchi
Journal:  Diabetes Care       Date:  2009-12-10       Impact factor: 19.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.